Average Price Target: $9.00
▲ +53.85% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Augmedix in the last 3 months. The average price target is $9.00, with a high forecast of $9.00 and a low forecast of $9.00. The average price target represents a 53.85% upside from the last price of $5.85.
The current consensus among 1 contributing investment analysts is to buy stock in Augmedix.
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. It offers software that is compatible with off-the-shelf, mobile client devices, which enables clinicians to communicate with remotely located documentation specialists (RDSs). The company's services include Augmedix Live, a real time service, in which RDSs provide medical documentation and live clinical support services; and Augmedix Notes, a non-real time product where RDSs offer medical documentation based upon recorded visits. Its clients include health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.